Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-21-000770
Filing Date
2021-08-13
Accepted
2021-08-13 17:31:01
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT opgn10qq2-0621.htm   iXBRL 10-Q 1588320
2 CERTIFICATION ex31x1.htm EX-31.1 7293
3 CERTIFICATION ex31x2.htm EX-31.2 7319
4 CERTIFICATION ex32x1.htm EX-32.1 4196
  Complete submission text file 0001079973-21-000770.txt   8543433

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE opgn-20210630.xsd EX-101.SCH 81195
6 XBRL CALCULATION FILE opgn-20210630_cal.xml EX-101.CAL 74609
7 XBRL DEFINITION FILE opgn-20210630_def.xml EX-101.DEF 306374
8 XBRL LABEL FILE opgn-20210630_lab.xml EX-101.LAB 488456
9 XBRL PRESENTATION FILE opgn-20210630_pre.xml EX-101.PRE 434111
10 EXTRACTED XBRL INSTANCE DOCUMENT opgn10qq2-0621_htm.xml XML 1590892
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37367 | Film No.: 211173510
SIC: 8071 Services-Medical Laboratories